New product: Darzalex (daratumumab) 1,800 mg solution for subcutaneous injection

This new strength (1800 mg in 15ml vial) and new route of administration is licensed for all existing indications e.g. treatment of multiple myeloma.

Source:

electronic Medicines compendium